查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1504917

医药品有效成分市场，占有率，规模，趋势，产业分析报告:各产品类型，不同形态，各厂商类型，各用途，各地区，各市场区隔预测，2024年～2032年

Active Pharmaceutical Ingredient Market Share, Size, Trends, Industry Analysis Report, By Product Type; By Form; By Manufacturer Type; By Application; By Regions; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的最新研究，到 2032 年，全球活性药物成分 (API) 市场规模预计将达到 3,158.4 亿美元。该报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

活性药物成分（API）是包含在成品药物（FPP）中的物质，具有治癒、缓解、诊断或治疗疾病，或改变、改变或恢復人类生理功能的药理活性。 。药品由多种成分组成，原料药是胶囊、锭剂等药品的主要成分。药品中使用的原料药的形式是热力学上最稳定的结晶形式。

对全球市场产生正面影响的主要因素包括新型冠状病毒的突然爆发，药品需求迅速增加，刺激了整体市场的成长。此外，人口老化以及心血管疾病、癌症、爱滋病和其他传染病发病率的增加，增加了对药品中使用的活性药物成分的需求。例如，根据世界卫生组织（WHO）2020年3月发布的报告，COVID-19病例数升至20万例，并将在近12天内突破10万例。此外，心血管疾病、肿瘤、糖尿病、生活方式相关疾病的盛行率上升以及老年人口的增加进一步推动了全球整体市场需求。

市场参与者艾伯维公司、雅保公司、阿斯特捷利康公司、Aurobindo Pharma、勃林格殷格翰公司、百时美施贵宝公司、西普拉公司、雷迪博士实验室有限公司、礼来公司、罗氏公司、葛兰素史克公司、Lonza Group、Merck &Co, Ltd.、Mylan NV、Novartis AG、Pfizer, Inc.、Sanofi、Sun Pharmaceutical Industries Ltd.、Teva Pharmaceutical Industries Ltd. 是在全球市场运营的一些主要公司。

市场参与者正在专注于活性药物成分的开发，以满足对治疗多种疾病的重要药物不断增长的需求。几十年来，治疗癌症、爱滋病毒、关节炎、B型肝炎、糖尿病、心血管疾病、爱滋病和各种其他疾病的药物创新和需求一直在增加。这进一步推动了过去几年和预测期内 API 的成长。

市场领导者正在加强其产品组合併增强其能力，以进一步确立其市场地位。例如，2020年7月，Advert International签署协议，由Micro Labs Ltd.以17亿美元收购综合製药公司RA Chem Pharma Ltd.。 Advert International 旨在打造领先的 API 平台之一，预计将利用其全球管理和财务资源来扩大 RA Chem Pharma 的规模。

目录

第1章 简介

第2章 摘要整理

第3章 调查手法

第4章 医药品有效成分市场洞察

  • 医药品有效成分- 产业概述
  • 医药品有效成分市场动态
    • 促进因素和机会
      • 感染疾病的剧增
      • 学名药的重要性提升
    • 阻碍因素与课题
      • 与药物相关的副作用
  • 大环境分析
  • 医药品有效成分市场产业趋势

第5章 各产品类型的医药品有效成分市场评估

  • 主要调查结果
  • 简介
    • 全球医药品有效成分市场，各产品类型，2015年～2026年
  • 单株抗体
    • 全球医药品有效成分市场，单株抗体，各地区，2016年～2027年
  • 免疫球蛋白
    • 全球医药品有效成分市场，免疫球蛋白，各地区，2016年～2027年
  • 细胞激素
    • 全球医药品有效成分市场，细胞激素，各地区，2016年～2027年
  • 胰岛素
    • 全球医药品有效成分市场，胰岛素，各地区，2016年～2027年
  • [月太]激素
    • 全球医药品有效成分市场，[月太]激素，各地区，2016年～2027年
  • 血液因子
    • 全球医药品有效成分市场，血液因子，各地区，2016年～2027年
  • [月太]抗生素
    • 全球医药品有效成分市场，[月太]抗生素，各地区，2016年～2027年
  • 疫苗
    • 全球医药品有效成分市场，疫苗，各地区，2016年～2027年
  • 低分子抗生素
    • 全球医药品有效成分市场，低分子抗生素，各地区，2016年～2027年
  • 高功效医药品有效成分(HPAPI)
    • 全球有效医药品成分市场，高功效医药品有效成分(HPAPI)，各地区，2016年～2027年
  • 其他
    • 全球医药品有效成分市场，其他，各地区，2016年～2027年

第6章 全球医药品有效成分市场:不同形态

  • 主要调查结果
  • 简介
  • 水性
  • 非水性液体
  • 干燥粉末

第7章 全球医药品有效成分市场:各製造厂商

  • 主要调查结果
  • 简介
  • 专卖
  • 业者

第8章 各用途医药品有效成分市场评估

  • 主要调查结果
  • 简介
    • 全球医药品有效成分市场，各用途，2015年～2026年
  • 心臟病
    • 全球医药品有效成分市场，心臟病，各地区，2016年～2027年
  • 肿瘤学
    • 全球医药品有效成分市场，肿瘤学，各地区，2016年～2027年
  • 中枢神经系统和神经学
    • 全球医药品有效成分市场，CNS及神经学，各地区，2016年～2027年
  • 整形外科
    • 全球医药品有效成分市场，整形外科各领域，各地区，2016年～2027年
  • 内分泌学
    • 全球医药品有效成分市场，内分泌学，各地区，2016年～2027年
  • 呼吸系统医疗设备
    • 全球医药品有效成分市场，呼吸系统医疗设备，各地区，2016年～2027年
  • 消化器官内科
    • 全球医药品有效成分市场，消化器官科，各地区，2016年～2027年
  • 肾臟学
    • 全球医药品有效成分市场，肾臟病，各地区，2016年～2027年
  • 眼科
    • 全球有效医药品成分市场，眼科，各地区，2016年～2027年
  • 其他
    • 全球医药品有效成分市场，其他的用途，各地区，2016年～2027年

第9章 地区的医药品有效成分市场评估

  • 主要调查结果
  • 简介
    • 医药品有效成分市场评估:地区，2016年～2027年
  • 北美
    • 北美:各产品类型，2016年～2027年
    • 北美:不同形态，2016年～2027年
    • 北美:各製造厂商，2016年～2027年
    • 北美:各用途，2016年～2027年
    • 美国
      • 美国:各产品类型，2016年～2027年
      • 美国:不同形态，2016年～2027年
      • 美国:各製造厂商，2016年～2027年
      • 美国:各用途，2016年～2027年
    • 加拿大
      • 加拿大:各产品类型，2016年～2027年
      • 加拿大:不同形态，2016年～2027年
      • 加拿大:各製造厂商，2016年～2027年
      • 加拿大:申请，2016年～2027年
  • 欧洲
    • 欧洲:各产品类型，2016年～2027年
    • 欧洲:不同形态，2016年～2027年
    • 欧洲:各製造厂商，2016年～2027年
    • 欧洲:各用途，2016年～2027年
    • 英国
      • 英国:各产品类型，2016年～2027年
      • 英国:不同形态，2016年～2027年
      • 英国:各製造厂商，2016年～2027年
      • 英国:各用途，2016年～2027年
    • 法国
      • 法国:各产品类型，2016年～2027年
      • 法国:不同形态，2016年～2027年
      • 法国:各製造厂商，2016年～2027年
      • 法国:申请，2016年～2027年
    • 德国
      • 德国:各产品类型，2016年～2027年
      • 德国:不同形态，2016年～2027年
      • 德国:各製造厂商，2016年～2027年
      • 德国:各用途，2016年～2027年
    • 义大利
      • 义大利:各产品类型，2016年～2027年
      • 义大利:不同形态，2016年～2027年
      • 义大利:各製造厂商，2016年～2027年
      • 义大利:申请，2016年～2027年
    • 西班牙
      • 西班牙:各产品类型，2016年～2027年
      • 西班牙:不同形态，2016年～2027年
      • 西班牙:各製造厂商，2016年～2027年
      • 西班牙:申请，2016年～2027年
    • 荷兰
      • 荷兰:各产品类型，2016年～2027年
      • 荷兰:不同形态，2016年～2027年
      • 荷兰:各製造厂商，2016年～2027年
      • 荷兰:申请，2016年～2027年
    • 奥地利
      • 奥地利:各产品类型，2016年～2027年
      • 奥地利:不同形态，2016年～2027年
      • 奥地利:各製造厂商，2016年～2027年
      • 奥地利:各用途，2016年～2027年
  • 亚太地区
    • 亚太地区:各产品类型，2016年～2027年
    • 亚太地区:不同形态，2016年～2027年
    • 亚太地区:各製造厂商，2016年～2027年
    • 亚太地区:各用途，2016年～2027年
    • 中国
      • 中国:各产品类型，2016年～2027年
      • 中国:不同形态，2016年～2027年
      • 中国:各製造厂商，2016年～2027年
      • 中国:各用途，2016年～2027年
    • 印度
      • 印度:各产品类型，2016年～2027年
      • 印度:不同形态，2016年～2027年
      • 印度:各製造厂商，2016年～2027年
      • 印度:各用途，2016年～2027年
    • 马来西亚
      • 马来西亚:各产品类型，2016年～2027年
      • 马来西亚:不同形态，2016年～2027年
      • 马来西亚:各製造厂商，2016年～2027年
      • 马来西亚:各用途，2016年～2027年
    • 日本
      • 日本:各产品类型，2016年～2027年
      • 日本:不同形态，2016年～2027年
      • 日本:各製造厂商，2016年～2027年
      • 日本:各用途，2016年～2027年
    • 印尼
      • 印尼:各产品类型，2016年～2027年
      • 印尼:不同形态，2016年～2027年
      • 印尼:各製造厂商，2016年～2027年
      • 印尼:各用途，2016年～2027年
    • 韩国
      • 韩国:各产品类型，2016年～2027年
      • 韩国:不同形态，2016年～2027年
      • 韩国:各製造厂商，2016年～2027年
      • 韩国:申请，2016年～2027年
  • 中东·非洲
    • 中东及非洲:各产品类型，2016年～2027年
    • 中东及非洲:不同形态，2016年～2027年
    • 中东及非洲:各製造厂商，2016年～2027年
    • 中东及非洲:各用途，2016年～2027年
    • 沙乌地阿拉伯
      • 沙乌地阿拉伯:各产品类型，2016年～2027年
      • 沙乌地阿拉伯:不同形态，2016年～2027年
      • 沙乌地阿拉伯:各製造厂商，2016年～2027年
      • 沙乌地阿拉伯:各用途，2016年～2027年
    • 阿拉伯联合大公国
      • UAE:各产品类型，2016年～2027年
      • UAE:不同形态，2016年～2027年
      • UAE:各製造厂商，2016年～2027年
      • UAE:各用途，2016年～2027年
    • 以色列
      • 以色列:各产品类型，2016年～2027年
      • 以色列:不同形态，2016年～2027年
      • 以色列:各製造厂商，2016年～2027年
      • 以色列:申请，2016年～2027年
    • 南非
      • 南非:各产品类型，2016年～2027年
      • 南非:不同形态，2016年～2027年
      • 南非:各製造厂商，2016年～2027年
      • 南非:各用途，2016年～2027年
  • 南美
    • 南美:各产品类型，2016年～2027年
    • 南美:不同形态，2016年～2027年
    • 南美:各製造厂商，2016年～2027年
    • 南美:各用途，2016年～2027年
    • 墨西哥
      • 墨西哥:各产品类型，2016年～2027年
      • 墨西哥:不同形态，2016年～2027年
      • 墨西哥:各製造厂商，2016年～2027年
      • 墨西哥:各用途，2016年～2027年
    • 巴西
      • 巴西:各产品类型，2016年～2027年
      • 巴西:不同形态，2016年～2027年
      • 巴西:各製造厂商，2016年～2027年
      • 巴西:各用途，2016年～2027年
    • 阿根廷
      • 阿根廷:各产品类型，2016年～2027年
      • 阿根廷:不同形态，2016年～2027年
      • 阿根廷:各製造厂商，2016年～2027年
      • 阿根廷:申请，2016年～2027年

第10章 竞争情形

  • 扩大和收购的分析
    • 与扩大收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • AbbVie Inc.
  • Albemarle Corporation
  • AstraZeneca
  • Aurobindo Pharma
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Cipla Inc.
  • Dr. Reddy's Laboratories Ltd.
  • ELI Lilly and Company
  • F. Hoffmann-La Roche AG
  • GlaxoSmithKline PLC
  • Lonza Group
  • Merck & Co., Inc.
  • Mylan N.V.
  • Novartis AG
  • Pfizer, Inc.
  • Sanofi
  • Sun Pharmaceutical Industries Ltd
  • Teva Pharmaceutical Industries Ltd.
Product Code: PM1703

The global active pharmaceutical ingredient (API) market size is expected to reach USD 315.84 billion by 2032 according to a new study by Polaris Market Research. The report "Active pharmaceutical Ingredient (API) market Share, Size, Trends, Industry Analysis Report, By Product Type (Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Highly Potent Active Pharmaceutical Ingredient (HPAPI), and Others); By Form (Aqueous, Non-Aqueous Liquid, and Dry Powder); By Manufacturer Type (Captive, and Merchant); By Application (Cardiology, Oncology, CNS & Neurology, Orthopedic, Endocrinology, Pulmonology, Gastroenterology, Nephrology, Ophthalmology, and Others), By Regions; Segment Forecast, 2020 -2027"gives a detailed insight into current market dynamics and provides analysis on future market growth.

Active Pharmaceutical Ingredient (API) is a substance involved in the finished pharmaceutical product (FPP), aimed to enhance the pharmacological activity or have direct impact in the cure, mitigation, diagnosis, treatment of disease or in modifying, correcting or restoring physiological functions in the human body. Drug products are composed of various components, API is the primary ingredient of a drug product, for instance, capsule or a tablet. APIs form used in the formulation is the most stable crystalline form, thermo-dynamically.

The prominent factors favoring the global market include the sudden outbreak of novel corona virus, which is rapidly escalating the demand for pharmaceuticals and thereby fueling the overall market growth. Additionally, rise in aging population, rising cases of cardiovascular diseases, cancer, AIDs, other infectious diseases, are further contributing to augmenting demand for APIs that are used in drugs. For instance, according to a report published in March 2020, by World Health Organization (WHO), the number of COVID-19 patients increased to 200,000 and in almost after twelve-day period, the number would exceed by 100,000. Moreover, rising incidence of cardiovascular, oncology, diabetes and lifestyle diseases coupled with rising geriatric populace is furthermore surging the overall demand for the global market.

Market participants such as AbbVie Inc., Albemarle Corporation, AstraZeneca, Aurobindo Pharma, Boehringer Ingelheim, Bristol-Myers Squibb, Cipla Inc., Dr. Reddy's Laboratories Ltd., ELI Lilly and Company, F. Hoffmann-La Roche, GlaxoSmithKline PLC, Lonza Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer, Inc., Sanofi, Sun Pharmaceutical Industries Ltd, and Teva Pharmaceutical Industries Ltd. are some of the key players operating in the global market.

Players in the market are focusing on developing active pharmaceutical Ingredient to suffice the rising demand of critical drugs for the treatment of numerous diseases. For the treatment of various diseases such as cancer, HIV, arthritis, Hepatitis-B, diabetes, cardiovascular diseases, Aids and various others, which are responsible for the majority of deaths across the globe, the innovation and demand for pharmaceuticals has witnessed elevated graph over the few decades. This has further resulted in rise in growth of API during the past years and also over the forecast period.

Major players in the market are strengthening their capabilities to enhance their product portfolio and further establish their market place. For instance, on July, 2020, Advert International signed an agreement for the acquisition of RA Chem Pharma Ltd, an integrated pharmaceutical company by Micro Labs Ltd. for USD 1.7 billion. Advert International aims for building one of the major API platforms and is expected to leverage their operational and financial resources across the globe to scale RA Chem Pharma.

Polaris Market Research has segmented the Active Pharmaceutical Ingredient market on the basis of product type, form, manufacturer type, application and region

Active Pharmaceutical Ingredient Product Type Outlook (Revenue - USD Million, 2016 - 2027)

  • Monoclonal Antibodies
  • Immunoglobulin
  • Cytokines
  • Insulin
  • Peptide Hormones
  • Blood Factors
  • Peptide Antibiotics
  • Vaccines
  • Small Molecule Antibiotics
  • Highly Potent Active Pharmaceutical Ingredient (HPAPI)
  • Others

Active Pharmaceutical Ingredient Form Outlook (Revenue - USD Million, 2016 - 2027)

  • Aqueous
  • Non-Aqueous Liquid
  • Dry Powder

Active Pharmaceutical Ingredient Manufacturer Type Outlook (Revenue - USD Million, 2016 - 2027)

  • Captive
  • Merchant

Active Pharmaceutical Ingredient Application Outlook (Revenue - USD Million, 2016 - 2027)

  • Cardiology
  • Oncology
  • CNS & Neurology
  • Orthopedic
  • Endocrinology
  • Pulmonology
  • Gastroenterology
  • Nephrology
  • Ophthalmology
  • Others

Active Pharmaceutical Ingredient Regional Outlook (Revenue - USD Million, 2016 - 2027)

  • North America
  • U.S.
  • Canada
  • Europe
  • France
  • Germany
  • UK
  • Italy
  • Spain
  • Netherlands
  • Austria
  • Asia Pacific
  • China
  • India
  • Japan
  • Malaysia
  • South Korea
  • Indonesia
  • Central & South America
  • Mexico
  • Brazil
  • Argentina
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Active Pharmaceutical Ingredient Market Insights

  • 4.1. Active Pharmaceutical Ingredient - Industry snapshot
  • 4.2. Active Pharmaceutical Ingredient Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Surge in the infectious diseases
      • 4.2.1.2. Growing Importance of Generics
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Side effects associated of drugs
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTLE Analysis
  • 4.5. Active Pharmaceutical Ingredient Market Industry trends

5. Active Pharmaceutical Ingredient Market Assessment by Product Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Active Pharmaceutical Ingredient Market, By Product Type, 2015 - 2026 (USD Million)
  • 5.3. Monoclonal Antibodies
    • 5.3.1. Global Active Pharmaceutical Ingredient Market, by Monoclonal Antibodies, by Region, 2016- 2027 (USD Million)
  • 5.4. Immunoglobulin
    • 5.4.1. Global Active Pharmaceutical Ingredient Market, by Immunoglobulin, by Region, 2016- 2027 (USD Million)
  • 5.5. Cytokines
    • 5.5.1. Global Active Pharmaceutical Ingredient Market, by Cytokines, by Region, 2016- 2027 (USD Million)
  • 5.6. Insulin
    • 5.6.1. Global Active Pharmaceutical Ingredient Market, by Insulin, by Region, 2016- 2027 (USD Million)
  • 5.7. Peptide Hormones
    • 5.7.1. Global Active Pharmaceutical Ingredient Market, by Peptide Hormones, by Region, 2016- 2027 (USD Million)
  • 5.8. Blood Factors
    • 5.8.1. Global Active Pharmaceutical Ingredient Market, by Blood Factors, by Region, 2016- 2027 (USD Million)
  • 5.9. Peptide Antibiotics
    • 5.9.1. Global Active Pharmaceutical Ingredient Market, by Peptide Antibiotics, by Region, 2016- 2027 (USD Million)
  • 5.10. Vaccines
    • 5.10.1. Global Active Pharmaceutical Ingredient Market, by Vaccines, by Region, 2016- 2027 (USD Million)
  • 5.11. Small Molecule Antibiotics
    • 5.11.1. Global Active Pharmaceutical Ingredient Market, by Small Molecule Antibiotics, by Region, 2016- 2027 (USD Million)
  • 5.12. Highly Potent Active Pharmaceutical Ingredient (HPAPI)
    • 5.12.1. Global Active Pharmaceutical Ingredient Market, by Highly Potent Active Pharmaceutical Ingredient (HPAPI), by Region, 2016- 2027 (USD Million)
  • 5.13. Others
    • 5.13.1. Global Active Pharmaceutical Ingredient Market, by Others, by Region, 2016- 2027 (USD Million)

6. Global Active Pharmaceutical Ingredient Market, by Form

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Active Pharmaceutical Ingredient Market, By Form, 2015 - 2026 (USD Million)
  • 6.3. Aqueous
    • 6.3.1. Global Active Pharmaceutical Ingredient Market, by Aqueous, By Region, 2016- 2027 (USD Million)
  • 6.4. Non-Aqueous Liquid
    • 6.4.1. Global Active Pharmaceutical Ingredient Market, by Non-Aqueous Liquid, by Region, 2016- 2027 (USD Million)
  • 6.5. Dry Powder
    • 6.5.1. Global Active Pharmaceutical Ingredient Market, by Dry Powder, by Region, 2016- 2027 (USD Million)

7. Global Active Pharmaceutical Ingredient Market, by Manufacturer

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Active Pharmaceutical Ingredient Market, By Manufacturer, 2015 - 2026 (USD Million)
  • 7.3. Captive
    • 7.3.1. Global Active Pharmaceutical Ingredient Market, by Captive, By Region, 2016- 2027 (USD Million)
  • 7.4. Merchant
    • 7.4.1. Global Active Pharmaceutical Ingredient Market, by Merchant, by Region, 2016- 2027 (USD Million)

8. Active Pharmaceutical Ingredient Market Assessment by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Active Pharmaceutical Ingredient Market, By Application, 2015 - 2026 (USD Million)
  • 8.3. Cardiology
    • 8.3.1. Global Active Pharmaceutical Ingredient Market, by Cardiology, by Region, 2016- 2027 (USD Million)
  • 8.4. Oncology
    • 8.4.1. Global Active Pharmaceutical Ingredient Market, by Oncology, by Region, 2016- 2027 (USD Million)
  • 8.5. CNS & Neurology
    • 8.5.1. Global Active Pharmaceutical Ingredient Market, by CNS & Neurology, by Region, 2016- 2027 (USD Million)
  • 8.6. Orthopedic
    • 8.6.1. Global Active Pharmaceutical Ingredient Market, by Orthopedic, by Region, 2016- 2027 (USD Million)
  • 8.7. Endocrinology
    • 8.7.1. Global Active Pharmaceutical Ingredient Market, by Endocrinology, by Region, 2016- 2027 (USD Million)
  • 8.8. Pulmonology
    • 8.8.1. Global Active Pharmaceutical Ingredient Market, by Pulmonology, by Region, 2016- 2027 (USD Million)
  • 8.9. Gastroenterology
    • 8.9.1. Global Active Pharmaceutical Ingredient Market, by Gastroenterology, by Region, 2016- 2027 (USD Million)
  • 8.10. Nephrology
    • 8.10.1. Global Active Pharmaceutical Ingredient Market, by Nephrology, by Region, 2016- 2027 (USD Million)
  • 8.11. Ophthalmology
    • 8.11.1. Global Active Pharmaceutical Ingredient Market, by Ophthalmology, by Region, 2016- 2027 (USD Million)
  • 8.12. Others
    • 8.12.1. Global Active Pharmaceutical Ingredient Market, by Other Applications, by Region, 2016- 2027 (USD Million)

9. Active Pharmaceutical Ingredient Market Assessment by Geography

  • 9.1. Key findings
  • 9.2. Introduction
    • 9.2.1. Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016- 2027 (USD Million)
  • 9.3. Active Pharmaceutical Ingredient Market - North America
    • 9.3.1. North America: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
    • 9.3.2. North America: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
    • 9.3.3. North America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
    • 9.3.4. North America: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.3.5. Active Pharmaceutical Ingredient Market - U.S.
      • 9.3.5.1. U.S.: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.3.5.2. U.S.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.3.5.3. U.S.: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.3.5.4. U.S.: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.3.6. Active Pharmaceutical Ingredient Market - Canada
      • 9.3.6.1. Canada: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.3.6.2. Canada.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.3.6.3. Canada: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.3.6.4. Canada: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
  • 9.4. Active Pharmaceutical Ingredient Market - Europe
    • 9.4.1. Europe: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
    • 9.4.2. Europe.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
    • 9.4.3. Europe: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
    • 9.4.4. Europe: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.4.5. Active Pharmaceutical Ingredient Market - UK
      • 9.4.5.1. UK: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.5.2. UK.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.4.5.3. UK: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.4.5.4. UK: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.4.6. Active Pharmaceutical Ingredient Market - France
      • 9.4.6.1. France: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.6.2. France.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.4.6.3. France: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.4.6.4. France: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.4.7. Active Pharmaceutical Ingredient Market - Germany
      • 9.4.7.1. Germany: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.7.2. Germany.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.4.7.3. Germany: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.4.7.4. Germany: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.4.8. Active Pharmaceutical Ingredient Market - Italy
      • 9.4.8.1. Italy: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.8.2. Italy.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.4.8.3. Italy: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.4.8.4. Italy: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.4.9. Active Pharmaceutical Ingredient Market - Spain
      • 9.4.9.1. Spain: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.9.2. Spain.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.4.9.3. Spain: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.4.9.4. Spain: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.4.10. Active Pharmaceutical Ingredient Market - Netherlands
      • 9.4.10.1. Netherlands: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.10.2. Netherlands.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.4.10.3. Netherlands: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.4.10.4. Netherlands: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.4.11. Active Pharmaceutical Ingredient Market - Austria
      • 9.4.11.1. Austria: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.4.11.2. Austria.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.4.11.3. Austria: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.4.11.4. Austria: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
  • 9.5. Active Pharmaceutical Ingredient Market - Asia-Pacific
    • 9.5.1. Asia Pacific: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
    • 9.5.2. Asia Pacific.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
    • 9.5.3. Asia-pacific: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
    • 9.5.4. Asia-pacific: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.5.5. Active Pharmaceutical Ingredient Market - China
      • 9.5.5.1. China: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.5.2. China.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.5.5.3. China: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.5.5.4. China: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.5.6. Active Pharmaceutical Ingredient Market - India
      • 9.5.6.1. India: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.6.2. India.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.5.6.3. India: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.5.6.4. India: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.5.7. Active Pharmaceutical Ingredient Market - Malaysia
      • 9.5.7.1. Malaysia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.7.2. Malaysia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.5.7.3. Malaysia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.5.7.4. Malaysia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.5.8. Active Pharmaceutical Ingredient Market - Japan
      • 9.5.8.1. Japan: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.8.2. Japan.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.5.8.3. Japan: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.5.8.4. Japan: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.5.9. Active Pharmaceutical Ingredient Market - Indonesia
      • 9.5.9.1. Indonesia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.9.2. Indonesia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.5.9.3. Indonesia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.5.9.4. Indonesia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.5.10. Active Pharmaceutical Ingredient Market - South Korea
      • 9.5.10.1. South Korea: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.5.10.2. South Korea.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.5.10.3. South Korea: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.5.10.4. South Korea: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
  • 9.6. Active Pharmaceutical Ingredient Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
    • 9.6.2. Middle East & Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
    • 9.6.3. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
    • 9.6.4. Middle East & Africa: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.6.5. Active Pharmaceutical Ingredient Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.6.5.2. Saudi Arabia.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.6.5.3. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.6.5.4. Saudi Arabia: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.6.6. Active Pharmaceutical Ingredient Market - UAE
      • 9.6.6.1. UAE: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.6.6.2. UAE.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.6.6.3. UAE: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.6.6.4. UAE: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.6.7. Active Pharmaceutical Ingredient Market - Israel
      • 9.6.7.1. Israel: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.6.7.2. Israel.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.6.7.3. Israel: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.6.7.4. Israel: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.6.8. Active Pharmaceutical Ingredient Market - South Africa
      • 9.6.8.1. South Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.6.8.2. South Africa.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.6.8.3. South Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.6.8.4. South Africa: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
  • 9.7. Active Pharmaceutical Ingredient Market - Latin America
    • 9.7.1. Latin America: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
    • 9.7.2. Latin America.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
    • 9.7.3. Latin America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
    • 9.7.4. Latin America: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.7.5. Active Pharmaceutical Ingredient Market - Mexico
      • 9.7.5.1. Mexico: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.7.5.2. Mexico.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.7.5.3. Mexico: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.7.5.4. Mexico: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.7.6. Active Pharmaceutical Ingredient Market - Brazil
      • 9.7.6.1. Brazil: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.7.6.2. Brazil.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.7.6.3. Brazil: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.7.6.4. Brazil: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)
    • 9.7.7. Active Pharmaceutical Ingredient Market - Argentina
      • 9.7.7.1. Argentina: Active Pharmaceutical Ingredient Market, By Product Type, 2016- 2027 (USD Million)
      • 9.7.7.2. Argentina.: Active Pharmaceutical Ingredient Market, By Form, 2016- 2027 (USD Million)
      • 9.7.7.3. Argentina: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016- 2027 (USD Million)
      • 9.7.7.4. Argentina: Active Pharmaceutical Ingredient Market, By Application, 2016- 2027 (USD Million)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion & Acquisition
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. AbbVie Inc.
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Albemarle Corporation
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. AstraZeneca
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. Aurobindo Pharma
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Boehringer Ingelheim
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Bristol-Myers Squibb
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. Cipla Inc.
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Dr. Reddy's Laboratories Ltd.
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. ELI Lilly and Company
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. F. Hoffmann-La Roche AG
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. GlaxoSmithKline PLC
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Lonza Group
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. Merck & Co., Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Mylan N.V.
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Novartis AG
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development
  • 11.16. Pfizer, Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Financial Performance
    • 11.16.3. Product Benchmarking
    • 11.16.4. Recent Development
  • 11.17. Sanofi
    • 11.17.1. Company Overview
    • 11.17.2. Financial Performance
    • 11.17.3. Product Benchmarking
    • 11.17.4. Recent Development
  • 11.18. Sun Pharmaceutical Industries Ltd
    • 11.18.1. Company Overview
    • 11.18.2. Financial Performance
    • 11.18.3. Product Benchmarking
    • 11.18.4. Recent Development
  • 11.19. Teva Pharmaceutical Industries Ltd.
    • 11.19.1. Company Overview
    • 11.19.2. Financial Performance
    • 11.19.3. Product Benchmarking
    • 11.19.4. Recent Development

List of Tables

  • Table 1 Global Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 2 Global Active Pharmaceutical Ingredient Market, by Form, by Region, 2016 - 2027 (USD Million)
  • Table 3 Global Active Pharmaceutical Ingredient Market, by Manufacturer, by Region, 2016 - 2027 (USD Million)
  • Table 4 Global Active Pharmaceutical Ingredient Market, by Application, by Region, 2016 - 2027 (USD Million)
  • Table 5 Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016 - 2027 (USD Million)
  • Table 6 North America: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 7 North America: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 8 North America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 9 North America: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 10 U.S.: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 11 U.S.: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 12 U.S.: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 13 U.S.: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 14 Canada: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 15 Canada: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 16 Canada: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 17 Canada: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 18 Europe: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 19 Europe: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 20 Europe: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 21 Europe: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 22 UK: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 23 UK: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 24 UK: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 25 UK: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 26 France: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 27 France: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 28 France: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 29 France: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 30 Germany: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 31 Germany: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 32 Germany: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 33 Germany: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 34 Italy: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 35 Italy: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 36 Italy: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 37 Italy: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 38 Netherlands: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 39 Netherlands: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 40 Netherlands: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 41 Netherlands: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 42 Austria: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 43 Austria: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 44 Austria: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 45 Austria: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 46 Asia Pacific: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 47 Asia Pacific: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 48 Asia Pacific: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 49 Asia Pacific: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 50 China: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 51 China: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 52 China: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 53 China: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 54 India: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 55 India: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 56 India: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 57 India: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 58 Japan: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 59 Japan: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 60 Japan: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 61 Japan: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 62 Malaysia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 63 Malaysia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 64 Malaysia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 65 Malaysia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 66 Indonesia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 67 Indonesia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 68 Indonesia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 69 Indonesia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 70 South Korea: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 71 South Korea: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 72 South Korea: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 73 South Korea: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 74 Middle East & Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 75 Middle East & Africa: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 76 Middle East & Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 77 Middle East & Africa: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 78 Saudi Arabia: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 79 Saudi Arabia: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 80 Saudi Arabia: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 81 Saudi Arabia: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 82 Israel: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 83 Israel: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 84 Israel: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 85 Israel: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 86 South Africa: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 87 South Africa: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 88 South Africa: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 89 South Africa: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 90 Latin America: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 91 Latin America: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 92 Latin America: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 93 Latin America: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 94 Brazil: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 95 Brazil: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 96 Brazil: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 97 Brazil: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 98 Mexico: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 99 Mexico: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 100 Mexico: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 101 Mexico: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)
  • Table 102 Argentina: Active Pharmaceutical Ingredient Market, By Product Type, 2016 - 2027 (USD Million)
  • Table 103 Argentina: Active Pharmaceutical Ingredient Market, By Form, 2016 - 2027 (USD Million)
  • Table 104 Argentina: Active Pharmaceutical Ingredient Market, By Manufacturer, 2016 - 2027 (USD Million)
  • Table 105 Argentina: Active Pharmaceutical Ingredient Market, By Application, 2016 - 2027 (USD Million)

List of Figures

  • Figure 1. Market Highlights (2019, Revenue)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top Down & Bottom Up Approach
  • Figure 4. Market by Geography
  • Figure 6. Porter's Five Forces
  • Figure 7. Market by Product Type
  • Figure 8. Global Active Pharmaceutical Ingredient Market, By Product Type, 2019 & 2027 (USD Million)
  • Figure 9. Market by Form
  • Figure 8. Global Active Pharmaceutical Ingredient Market, By Form, 2019 & 2027 (USD Million)
  • Figure 9. Market by Manufacturer
  • Figure 10. Global Active Pharmaceutical Ingredient Market, By Manufacturer, 2019 & 2027 (USD Million)
  • Figure 11. Market by Application
  • Figure 12. Global Active Pharmaceutical Ingredient Market, By Application, 2019 & 2027 (USD Million)
  • Figure 13. Active Pharmaceutical Ingredient Market Assessment, By Geography, 2016- 2027 (USD Million)
  • Figure 14. Strategic Analysis - Active Pharmaceutical Ingredient Market